MEDG Medgenics(Regs)

TIDMMEDG TIDMMEDU

RNS Number : 7033U

Medgenics Inc

04 December 2013

 
 Press Release   04 December 2013 
 

Directors Dealings

Medgenics, Inc. (AIM: MEDU, MEDG and NYSE MKT: MDGN), the developer of Biopump(TM) , a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that on 2 December 2013 and 3 December 2013, the Company was informed by Dr. Eugene Bauer, a Director of the Company, that he sold a total of 20,000 shares of common stock on the open market on those days at an average price of $6.30 per share.

Following this sale Dr. Bauer owns 195,874 shares of common stock representing approximately 1.1 per cent of the issued share capital. Dr. Bauer also has the right to purchase up to 78,571 shares of common stock pursuant to warrants and options previously granted (in aggregate Dr. Bauer's shares of common stock, warrants, and options represent 274,445 shares of common stock which represent approximately 1.5 per cent of the issued share capital).

This announcement is being made pursuant to the London Stock Exchange's AIM Rules for Companies admitted to trading on the AIM market.

About Medgenics

Medgenics is developing and commercializing Biopump(TM), a proprietary tissue-based platform technology for the sustained production and delivery of therapeutic proteins using the patient's own tissue for the treatment of a range of chronic diseases including anemia, hepatitis, among others. For more information, please visit www.medgenics.com.

Contacts:

 
 Medgenics, Inc. 
  John Leaman, CFO 
  john.leaman@medgenics.com 
 
  LHA 
  Anne Marie Fields 
  212-838-3777 
  afields@lhai.com 
  @LHA_IR_PR 
 Abchurch Communications 
  Joanne Shears / Jamie Hooper 
  / Harriet Rae 
  harriet.rae@abchurch-group.com      +44 207 398 7718 
 Oriel Securities (NOMAD & Broker) 
  Jonathan Senior / Giles Balleny     +44 207 710 7617 
 

-Ends-

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUSAOROVAURAA

Medgenics(Regs) (LSE:MEDG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Medgenics(Regs) (LSE:MEDG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024